书签 分享 收藏 举报 版权申诉 / 64
上传文档赚钱

类型抗生素英文课件-Choosing-Antibiotics-Before-and-After-t.ppt

  • 上传人(卖家):晟晟文业
  • 文档编号:5110777
  • 上传时间:2023-02-12
  • 格式:PPT
  • 页数:64
  • 大小:2.47MB
  • 【下载声明】
    1. 本站全部试题类文档,若标题没写含答案,则无答案;标题注明含答案的文档,主观题也可能无答案。请谨慎下单,一旦售出,不予退换。
    2. 本站全部PPT文档均不含视频和音频,PPT中出现的音频或视频标识(或文字)仅表示流程,实际无音频或视频文件。请谨慎下单,一旦售出,不予退换。
    3. 本页资料《抗生素英文课件-Choosing-Antibiotics-Before-and-After-t.ppt》由用户(晟晟文业)主动上传,其收益全归该用户。163文库仅提供信息存储空间,仅对该用户上传内容的表现方式做保护处理,对上传内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(点击联系客服),我们立即给予删除!
    4. 请根据预览情况,自愿下载本文。本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
    5. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007及以上版本和PDF阅读器,压缩文件请下载最新的WinRAR软件解压。
    配套讲稿:

    如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。

    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    抗生素 英文 课件 Choosing Antibiotics Before and After
    资源描述:

    1、Choosing Antibiotics:Before and After the Culture ResultsGopi Patel,MDAugust 20,2010ProphylaxisEmpiricTargetedPicking AntibioticsWhat has the patient grown before?What is the patient growing now?What is the patient at risk for growing?What are the patients signs and symptoms?Antibiotic selectionRisk

    2、 factors for drug resistance Recent antimicrobial exposuresUnderlying comorbidities AllergiesRecent interventionsAvailable and previous culture data History of MRSA,VRE,Pseudomonas ESBL-producing GNRThe flora and fauna of the hospital And perhaps even the unit How sick is the patient?Can always“go b

    3、ig”and narrow as you get more informationJust to refresh your memoryCephalosporins*1stCefazolinCephalexin Gram-positive cocci(e.g.,MSSA,GBS)E.coli,K.pneumoniae,P.mirabilis2ndCefuroximeCefoxitinCefotetan Cefuroxime-H.influenzae Cephamycins-Bacteroides spp3rdCefotaximeCeftriaxoneCeftazidime Some anaer

    4、obic coverage Ceftazidime-Pseudomonas Crosses the BBB Potent inducers of-lactamases4thCefepime Pseudomonas Crosses the BBB Stable against many-lactamases*Do NOT cover Enterococcus,Listeria,Legionella,or MRSACase 1 48 M IVDA admitted with fevers and chills Fresh track marks on Left arm Febrile to 39

    5、BP 70/55 HR 112 93%RA III/VI systolic murmur at LLSB B/L crackles Chest X-ray-Congestion B/L Empiric antibiotics?As expected At 14 hours both sets of blood cultures are growing Gram-positive cocci in clusters Previous history of MRSA TTE cant rule out vegetation on mitral valve TEE refused Patient g

    6、rows MRSA Vancomycin continuedVancomycin Discovered in 1956 Mechanism of action Inhibits bacterial cell wall synthesis Binds firmly to D-Ala-D-Ala of the peptidoglycan,preventing elongation and cross-linking Mechanism of resistance Altered peptidoglycan binding site D-Ala-D-Ala is replaced by D-Ala-

    7、D-lactate Thickened cell wallToxicity Nephrotoxicity Most often in the setting of other nephrotoxic agents and unstable renal function Hypersensitivity reactions1 Red man syndrome Anaphylaxis Rare reactions Ototoxicity Neutropenia and/or thrombocytopenia2 Linear IgA bullous dermatosis1 Crit Care.200

    8、3;7(2)119-202 NEJM.2007;356(9)904-910Linear IgA Bullous DermatosisDosingDosingCrCl(mL/min)Dosing Regimen 7015 mg/kg every 8-12 hours40-6915 mg/kg every 12-24 hours 10 mg/L Minimum troughs of 15-20 mg/L are recommended for severe or complicated infections(endocarditis,osteomyelitis,meningitis,and pne

    9、umonia)1 Am J Resp Crit Care Med.2005;171:338.2 Clin Infect Dis.2004;39:1267-84.3 Circulation.2005;111:e394-e433.What if a person cant“tolerate”Vanco?-Anaphylaxis-Patient“refuses”drug-Cant get the right levels-Ease of dosingDaptomycin FDA approved in 2003 Depolarizes the cell membrane and is rapidly

    10、 bactericidal against Gram-positives Approved for the treatment of complicated skin and skin structure infections S.aureus(including MRSA),GAS,Streptococcus agalactiae,and vanco-susceptible Enterococcus faecalis Not approved for E.faecium(CLSI breakpoint 4)Non-inferior to vanco and anti-staph penici

    11、llins in S.aureus bacteremia and right-sided endocarditis1 Jury is out for left-sided endocarditis NOT indicated for treatment of pneumonia1 NEJM.2006;355(7):652-65 Dosing Use actual body weight For serious,life-threatening infections dosing regimens of 8 to 12 mg/kg have been used1 Requires 24-hour

    12、 Antibiotic ApprovalIndicationCrCl(mL/min)DoseSSTI 30 30(HD)4 mg/kg every 24 hrs4 mg/kg every 48 hrsBacteremia 30100,000 CFU/mL GRAM NEGATIVE BACILLIIsolate 01 Klebsiella pneumoniae,an ESBL producerCONTACT PRECAUTIONSANTIBIOTICS Mic SYSTEMIC URINE Aztreonam 16 R Ceftriaxone 16 R*Cefepime 16 R*Cefuro

    13、xime 16 R*Tetracycline 4 S Ertapenem 2 S Gentamicin 4S Imipenem 4 S Levofloxacin 2 S Trimethoprim/Sulf16 R Ceftriaxone 16 R*Cefepime 16 R*Cefuroxime 16 R*Tetracycline 4 S Ertapenem 2 S Gentamicin 4S Imipenem 2 R Trimethoprim/Sulf16/8 R Aztreonam 16 R Ceftriaxone 32 R Ceftazidime 16 R Ciprofloxacin 2

    14、R Cefepime 16 R Amikacin 32 R Ertapenem 4 R Gentamicin 8 R Levofloxacin 4 R Meropenem 8 R Piperacillin/tazo 64 R Trimethoprim/Sulf2/38 R Tetracycline 4 R Tobramycin 8 R Call an ID fellow a.Use only when organisms are resistant to narrower spectrum agents.Aminoglycosides Cephalosporins-Lactams Miscel

    15、laneous Gentamicin Tobramycin Amikacina Cefazolin Cefuroxime Cefoxitin Ceftriaxone Ceftazidimea Cefepimea Ampicillin Ampicillin-sulbactama Piperacillin-tazobactam a Aztreonam Ertapenema Meropenema Imipenema Levofloxacin Ciprofloxacin Nitrofurantoin*Tetracycline SMZ-TMP Gram-negative species Escheric

    16、hia coli(n=1680)83 79 98 71 65 88 84 84 86 36 42 92 84 99 99 99 57 57 94 61 63 Klebsiella pneumoniae(n=1045)76 55 70 49 49 57 53 53 54 0 47 57 52 64 65 66 56 54 31 67 53 Klebsiella oxytoca(n=93)94 91 97 53 83 91 90 95 93 0 70 86 91 97 97 98 94 87 79 87 86 Pseudomonas aeruginosa(n=610)76 93 93 86 86

    17、84 69 86 80 68 69 Acinetobacter baumannii#(n=361)29 40 45 12 23 20 38*15 23 21 18 16 22 28 Proteus mirabilis(n=332)84 84 96 82 92 95 92 92 93 71 89 97 86 99 99 99 75 71 80 Erterobacter cloacae(n=230)73 70 97 0 24 0 52 54 67 0 19 61 54 74 76 76 70 67 22 71 62 Morganella morganii(n=118)80 89 98 0 9 81

    18、 92 88 98 0 8 94 88 99 99 99 74 70 40 65 Serratia marcescens(n=103)98 87 96 0 0 14 85 75 92 0 0 75 80 96 98 97 97 92 21 92 Stenotrophomonas maltophilia(N=94)47 88 98 Enterobacter aerogenes(n=80)89 81 91 0 46 0 70 68 85 0 30 80 78 89 93 93 88 85 70 76 Citrobacter freundii(n=79)91 91 100 0 48 9 76 79

    19、92 10 47 87 71 100 100 100 88 87 81 78 85 Susceptibilities at MSH 2009CarbapenemGentAmikTobraE.coli99%K.pneumoniae64%(E)76%70%55%P.aeruginosa86%(M)76%93%93%A.baumannii21%(I)29%45%40%E.cloacae76%(E)73%97%70%Other susceptibilitiesTigecyclinePolymyxinK.pneumoniae75%84%A.baumannii13%97%E.cloacae58%92%A.

    20、baumannii-38%susceptible to sulbactam component of amp-sulbactamCase 4 55 F DM,HTN,PVD,ESRD on HD Admitted with hyperglycemia/HONK Transferred out of MICU to 9W after stabilized on HD#3 On HD#5 febrile to 38.7 and lethargic CXR ordered Blood cultures sent U/A and Urine cultures orderedCXRLateralEmpi

    21、ric Antibiotics Hospital-Acquired Pneumonia 48 hours after admission Ventilator-Associated Pneumonia Healthcare-Associated PneumoniaHealthcare-associated Pneumonia Most recent guidelines emphasize obtaining lower respiratory tract cultures Early,appropriate broad-spectrum antibiotics at the adequate

    22、 doses Microbiology varies from one hospital to another and one unit to another Narrowing coverage Shorter durations The role for anaerobic coverage and“aspiration pneumonia”Pip-tazo vs.CefepimePip-TazoProsAmpicillin-susceptible EnterococcusAnaerobesConsPotent inducer of beta-lactamase production“Hi

    23、gher salt load”CefepimeProsMore stable against many beta-lactamases including some ESBLsBetter GNR drug here at MSH?(personal opinion)CheaperConsNo activity against Enterococcus or Anaerobes“Aspiration”and the Anaerobe Do you need to add metronidazole or clindamycin?Rarely necessary Levofloxacin and

    24、 ceftriaxone have some anaerobic activity Most pneumonia arises from aspiration of bacteria colonizing the oropharynx/nasopharynx Awful dentition(different from lack of dentition)Abscess formation Usually a more indolent presentation Chemical pneumonitis Aspiration of gastric contents vs.aspiration

    25、of bowel contents Where do anaerobes live?Use antibiotics with thoughtHelpful Hints What has the patient grown before?Previous antibiotic exposures If the patient is in contact isolation from admission chances are they grew something in the past SCC is probably the best system to look at cultures Wh

    26、at is the patient at risk for growing now?Previous antibiotic exposures Recent interventions What is the patient growing now?Narrow coverage Limiting antibiotic exposuresCall for adviceAntibiotic Approval 9407General ID 0649Transplant ID 8679Pop Quiz 47 yo F s/p allo SCT 8/08 complicated by GVHD of

    27、the skin and gut,CMV viremia,and presumed aspergillus with worsening shortness of breath and B/L nodular infiltrates Intubated on 11C and comes to MICU on Linezolid,Imipenem,Tigecycline,Gentamicin,Azithromycin,Ambisome,and GanciclovirPop Quiz Sputum gram stain with 1-9 PMNs Blood cultures with GNR in aerobic bottle at 5 hours What do you add?A.Bactrim B.Inhaled colistin C.Levofloxacin D.Palliative care consultStenotrophomonas maltophilia Inherently resistant to Carbapenems Drug of choice is TMP-SMXTMP-SMXLevoCeftazS.maltophilia98%88%47%

    展开阅读全文
    提示  163文库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:抗生素英文课件-Choosing-Antibiotics-Before-and-After-t.ppt
    链接地址:https://www.163wenku.com/p-5110777.html

    Copyright@ 2017-2037 Www.163WenKu.Com  网站版权所有  |  资源地图   
    IPC备案号:蜀ICP备2021032737号  | 川公网安备 51099002000191号


    侵权投诉QQ:3464097650  资料上传QQ:3464097650
       


    【声明】本站为“文档C2C交易模式”,即用户上传的文档直接卖给(下载)用户,本站只是网络空间服务平台,本站所有原创文档下载所得归上传人所有,如您发现上传作品侵犯了您的版权,请立刻联系我们并提供证据,我们将在3个工作日内予以改正。

    163文库